Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Loza

Showing results (51-60 of 52) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 52 results.
Annals of the Rheumatic Diseases|May 17, 2017
Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trialHermine I Brunner, Nicolino Ruperto, Nikolay Tzaribachev, et al.
The Journal of Allergy and Clinical Immunology|June 15, 2018
Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammationZala Jevnikar, Jörgen Östling, Elisabeth Ax, et al.
Pageof 6

Showing results (51-60 of 52) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 52 results.
Annals of the Rheumatic Diseases|May 17, 2017
Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trialHermine I Brunner, Nicolino Ruperto, Nikolay Tzaribachev, et al.
The Journal of Allergy and Clinical Immunology|June 15, 2018
Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammationZala Jevnikar, Jörgen Östling, Elisabeth Ax, et al.
Pageof 6